Genetic Testing in the Management of Adult CKD

Chebib, F; et al. Journal of the American Society of Nephrology 2025

ctDNA Monitoring in Ovarian Cancer Patients Receiving PARPi

Toboni, Michael D, et al. Gynecologic Oncology 204 (2026)

Tumor-Informed ctDNA Assay to Predict Outcome in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Treated with PD-1

Using Circulating Tumor DNA–Based Molecular Residual Disease Detection for Postoperative Monitoring in Early-Stage Uterine Cancer

Ketch et al. JCO PO 2025

Feasibility of Personalized and Tumor-Informed Circulating Tumor DNA Assay for Early Recurrence Detection in Patients With Hepatocellular Ca

Abdelrahim M, et al. JCO Preci Oncol. 2025

Longitudinal circulating tumor DNA analysis during treatment of locally advanced resectable gastric or gastroesophageal junction adenocarcin

Zaanan et al. Nat Commun, 2025

A Two-Threshold Algorithm using Donor-derived Cell-free DNA Fraction and Quantity to Detect Acute Rejection After Heart Transplantation

Clinical Validation of a Prenatal Cell-Free DNA Screening Test for Fetal RHD in a Large U.S. Cohort

Gilstrop Thompson, et al. OBSTETRICS & GYNECOLOGY 2024

Early real-world experience monitoring circulating tumor DNA in resected early-stage non–small cell lung cancer

Martin T, Dinerman A, Sudhaman S, et al. J Thorac Cardiovasc Surg. 2024

ctDNA as an Adjunct to Posttreatment PET for Head and Neck Cancer Recurrence Risk Assessment

Lele SJ, Adilbay D, Lewis E, et al. Otolaryngology–Head and Neck Surgery. 2024

Genetics of Chronic Kidney Disease

Vivante, Asaf; NEJM 2024

ctDNA-based molecular residual disease and survival in resectable colorectal cancer

Nakamura, et al. Nature Medicine 2024

Circulating Tumor DNA Assay Detects Merkel Cell Carcinoma Recurrence, Disease Progression, and Minimal Residual Disease: Surveillance and Pr

Akaike T, Thakuria M, Silk AW, et al. J Clin Oncol. 2024

Personalized ctDNA for Monitoring Disease Status in Head and Neck Squamous Cell Carcinoma

Hanna GJ, Dennis MJ, Scarfo N, et al., Clinical Cancer Research. 2024

Advancing Genetic Testing in Kidney Diseases: Report From a National Kidney Foundation Working Group

Elevations of dd-cfDNA before bpAR ProActive Study Publication with Supplement April 2024

Bromberg, et al. Transplantation 2024

Analysis of Circulating Tumor DNA to Predict Risk of Recurrence in Patients With Esophageal and Gastric Cancers

Huffman BM, Aushev VN, Budde GL, et al. JCO-Precision Oncology. 2022

ctDNA-based detection of molecular residual disease in stage I-III NSCLC patients treated with definitive radiotherapy

Lebow, E; et al. Frontiers in Oncology

Antibody-mediated Rejection Without Detectable Donor-specific Antibody Releases Donor-derived Cell-free DNA

Halloran PF, Reeve J, Madill-Thomsen KS, et al. Transplantation. 2022